Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.

Digestive Diseases and Sciences
D RostA Stiehl

Abstract

In primary sclerosing cholangitis (PSC), biliary enrichment of ursodeoxycholic acid (UDCA) may represent the decisive factor for its presumable beneficial effect. Up to now it is not clear how colitis and colectomy with ileo-anal pouch affect the biliary enrichment of UDCA and the biliary bile acid composition. We determined the biliary bile acid composition in 63 patients with PSC including 7 patients with ileo-anal pouch, 31 patients with colitis, and 25 patients without colitis. No differences existed between patients with and those without colitis. In patients with colectomy and pouch at a UDCA dose of 17.7 +/- 1.6 mg/kg (n = 7), biliary UDCA represented 46.4 +/- 6.7% (mean +/- SD) of total bile acids. An increase in the dose in six pouch patients from 12.5 +/- 0.9 to 22.3 +/- 1.6 mg/kg led to a slight increase in biliary enrichment of UDCA, from 39.8 +/- 8.1 to 49.4 +/- 10.7%. In five of seven patients with ileo-anal pouch, biliary UDCA enrichment was within the normal range, and in two of seven it was permanently or intermittently abnormally low. During UDCA treatment, in pouch patients the biliary content of deoxycholic acid and lithocholic acid was reduced, whereas all other bile acids were unchanged. In a minority of p...Continue Reading

References

Sep 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·U BeuersG Paumgartner
Jun 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J PalmaA M Danitz
Nov 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D M HeumanZ R Vlahcevic
Dec 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A CrosignaniK D Setchell
Nov 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P MarteauR Poupon
Sep 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P R GalleA Stiehl
Oct 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A K BattaS Katz
Feb 7, 1982·Life Sciences·K Kitani, S Kanai
Aug 18, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·A StiehlS Walker
May 1, 1994·Gastroenterology·K D LindorS M Lange
Jan 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P InvernizziM Podda
Apr 29, 1999·Digestive Diseases and Sciences·P SauerA Stiehl
May 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B CombesA F Hofmann
Sep 7, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Daniel RostAdolf Stiehl

❮ Previous
Next ❯

Citations

Mar 30, 2007·Current Treatment Options in Gastroenterology·Daniel RostAdolf Stiehl
Apr 7, 2007·Current Opinion in Gastroenterology·James Rl Maggs, Roger W Chapman
Jun 22, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Emmanouil SinakosKeith Lindor
May 10, 2007·European Journal of Gastroenterology & Hepatology·Gerda RudolphAdolf Stiehl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.